Effects of combined treatment with zibotentan and dapagliflozin compared to dapagliflozin alone in patients with diabetic and non-diabetic chronic kidney disease.
Saved in:
| Title: | Effects of combined treatment with zibotentan and dapagliflozin compared to dapagliflozin alone in patients with diabetic and non-diabetic chronic kidney disease. |
|---|---|
| Authors: | Wasehuus V; Steno Diabetes Center Copenhagen, Herlev, Denmark., Smeijer JD; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Ambery P; BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Greasley PJ; BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Wijkmark E; BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Wheeler DC; Centre for Kidney and Bladder Health, University College London, London, UK., Rossing P; Steno Diabetes Center Copenhagen, Herlev, Denmark.; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Heerspink HJL; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.; George Institute for Global Health, Barangaroo, New South Wales, Australia. |
| Source: | Diabetes, obesity & metabolism [Diabetes Obes Metab] 2025 Aug; Vol. 27 (8), pp. 4311-4319. Date of Electronic Publication: 2025 May 21. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Multicenter Study; Clinical Trial, Phase II; Comparative Study |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1463-1326 (Electronic) Linking ISSN: 14628902 NLM ISO Abbreviation: Diabetes Obes Metab Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1463-1326 |
|---|---|
| DOI: | 10.1111/dom.16468 |
